SOPHiA GENETICS Closes $57.5 Million Public Offering
SOPHiA GENETICS announced the closing of an underwritten public offering, raising $57.5 million, following strong investor demand that led to the full exercise of the underwriters’ option to purchase additional shares. The company sold a total of 12,104,900 ordinary shares at a price of $4.75 per share, with TD Cowen acting as the lead book-running manager.
BOSTON and ROLLE, Switzerland, June 19, 2026 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the closing of its previously announced underwritten public offering with total gross proceeds of $57.5 million, before deducting…